Methods 12 Tumor Markers(CA199?NSE?CEA?CA242?Ferrtin?β-HCG?AFP?f-PSA?PSA?CA125?HGH?CA153) of 373 patients of digestive system neoplasm, 105 benign tumor patients of digestive system and 122 healthy persons were detected by using the technology of Protein Chip.
Results The levels of TK1 in breast cancer patients before operation, patients with benign breast tumor, non tumor patients, and healthy volunteers were (39.3± 33.9), (3.7±3.9), (1.7±0.5) and (1.4±0.5) pmol/L respectively.
The GPI activity of progressive stage or relapse and metastasis of patients with cancer was (197.26±93.74) IU/L( ± s ) and higher than (84.57±43.38) IU/L( ± s ) in relieved stage patients with cancer, P <0 05。
Based on these findings cytokine/TKD-activated NK cells were adoptively transferred in tumor patients.
In case of emergency in tumor patients, differential diagnosis should always include non-tumor related causes (e.
Tumor patients in need of critical care medicine often ignite discussions between hemato-oncologists and intensive care physicians regarding benefit, reason and objectives of intensive care therapy gainst the background of narrow resources.
Fifteen brain tumor patients were treated with slow neutron.
Multimodality Diagnostics and Megatherapy in Poor Prognosis Ewing's Tumor Patients
For other patients with malignant diseases the use of a new score system developed for patients with cancer can be helpful in the clinical decision making.
This was particularly striking in patients with cancer.
The effects of analgesic, thermoregulatory and endocrine functions of administering morphine sulphate (0.3mg) into the lateral cerebral ventricle via an Ommaya catheter were assessed in eight patients with cancer pain.
The results indicate that activation of opiate receptors in the brain produced pain relief, hypothermia (due to cutaneous vasodilation and sweating), and increased blood levels of prolactin, growth hormone and glucose in patients with cancer pain.
This may provide an explanation for the relatively rare occurrence of PNS in patients with cancer.
In contrast, hematological or hemostaseological tumor signs can be demonstrated nearly in every tumor patient, mostly, however, after prolonged disease.
In a phase I study a cytotoxic activity in the serum of a tumor patient given infusions of synthetic alkyl-lysophospholipid has been demonstrated.
Lymphocyte and monocyte counts were almost identical in the control and all tumor patient groups.
Each tumor patient's general health and life expectancy must be honestly assessed prior to aesthetic surgery, because operating on an individual who cannot survive to enjoy the benefits is injudicious.
In experiments reported here, glioma cell lines and explant cells from a tumor patient were exposed to 2, 4 and 8 mM phenylbutyrate and compared to untreated control cells.